News
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
13 Mar 24
Analyst Color, Biotech, Large Cap, Mid Cap, Health Care, Small Cap, Top Stories, Small Business, Analyst Ratings, Tech, General
A Glimpse Into The Expert Outlook On Waters Through 4 Analysts
12 Feb 24
Analyst Ratings
Waters Q4 Earnings Beats Estimates, CEO Touts Strong Execution In Tough Market Conditions
6 Feb 24
Earnings, Equities, News, Guidance, Markets, General
Waters Q4 Adj EPS $3.62 Beats $3.55 Estimate, Sales $819.47M Beat $815.03M Estimate
6 Feb 24
Earnings, News
Earnings Scheduled For February 6, 2024
6 Feb 24
Earnings
The Latest Analyst Ratings For Waters
25 Jan 24
Analyst Ratings
Barclays Maintains Underweight on Waters, Raises Price Target to $275
25 Jan 24
News, Price Target, Analyst Ratings
Press releases
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges
14 Mar 24
Commodities, Press Releases
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
13 Mar 24
Press Releases
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
22 Feb 24
Press Releases
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results
6 Feb 24
Earnings, Press Releases
Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call
18 Jan 24
Commodities, Press Releases